Acelyrin Q3 EPS $(0.87) Misses $(0.47) Estimate
Portfolio Pulse from Benzinga Newsdesk
Acelyrin (NASDAQ:SLRN) reported Q3 losses of $(0.87) per share, missing the analyst consensus estimate of $(0.47) by 85.11 percent.
November 07, 2023 | 9:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Acelyrin's Q3 earnings per share (EPS) of $(0.87) missed the analyst consensus estimate by 85.11%, which could negatively impact the stock price.
Earnings reports are a key indicator of a company's financial health. A significant miss on earnings estimates like Acelyrin's can lead to a decrease in the company's stock price as it indicates that the company is not performing as well as expected.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100